Our Aims and Objectives 

The aims and objectives of the Society are to improve the treatment of patients with myeloma by developing and promoting clinical trials of myeloma treatment and linked scientific studies, encouraging collaborative research and innovation in myeloma care. Developing guidelines for the management of patients with myeloma. Promoting knowledge through the education of healthcare professionals and patients in all aspects of the disease. Promoting patient access to treatment through advocacy and working with stakeholders and partners.